In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Frovatriptan Succinate Hydrate Drug Master File in Korea (Frovatriptan Succinate Hydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Frovatriptan Succinate Hydrate. The MFDS reviews the Frovatriptan Succinate Hydrate KDMF as part of the drug registration process and uses the information provided in the Frovatriptan Succinate Hydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Frovatriptan Succinate Hydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Frovatriptan Succinate Hydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Frovatriptan Succinate Hydrate suppliers with KDMF on PharmaCompass.